Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Derma Sciences Inc (NASDAQ:DSCI)

5.04
Delayed Data
As of 3:59pm ET
 -0.24 / -4.55%
Today’s Change
2.85
Today|||52-Week Range
6.81
+10.28%
Year-to-Date
LabCorp Q2 Results Strong, Sequenom Buyout Raises Hope
Aug 19 / Zacks.com - Paid Partner Content
New Strong Buy Stocks for August 11th
Aug 11 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close5.28
Today’s open5.26
Day’s range4.95 - 5.35
Volume67,624
Average volume (3 months)47,527
Market cap$149.5M
Dividend yield--
Data as of 3:59pm ET, 08/23/2016

Growth & Valuation

Earnings growth (last year)+8.64%
Earnings growth (this year)+97.30%
Earnings growth (next 5 years)--
Revenue growth (last year)+0.87%
P/E ratioNM
Price/Sales1.39
Price/Book1.39

Competitors

 Today’s
change
Today’s
% change
EYESSecond Sight Medical...+0.13+3.66%
SIENSientra Inc-0.08-0.99%
RTIXRTI Surgical Inc+0.02+0.60%
EDAPEdap Tms SA+0.01+0.32%
Data as of 4:00pm ET, 08/23/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$84.5M
Annual profit (last year)-$38.1M
Net profit margin-24.11%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Executive Chairman &
Chief Executive Officer
Stephen T. Wills
Executive Vice President-
Operations
Frederic Eigner
Corporate headquarters
Princeton, New Jersey

Forecasts

Partner Offers

Search for Jobs